& Lomb Pharmaceuticals Recalls Erythromycin Ophthalmic Ointment
August 17, 1999
Tampa, FL (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Bausch & Lomb Pharmaceuticals is recalling
Erythromycin Ophthalmic Ointment because of a product mix-up. Correctly labeled Muro
128Æ Ointment tube (sodium chloride 5%) was found in a carton of erythromycin product.
Erythromycin Ophthalmic Ointment, USP, 0.5%, Rx, in
3.5 g tubes.
Lot #065151 EXP 5/00.
Bausch & Lomb Pharmaceuticals, Inc., Tampa, Florida.
Manufacturer, by letter mailed on July 22, 1999, followed by letter and telephone.
Firm-initiated recall ongoing.
49,968 units were distributed.